A dietary approach to prevent hypertension: a review of the Dietary Approaches to Stop Hypertension (DASH) Study
This finding is particularly significant as it demonstrates that the cardiovascular benefits of GLP-1 agonists extend beyond their glucose-lowering effects to encompass direct cardiovascular protection in obesity
Do not discontinue GLP-1 medications without medical guidance, as this may worsen blood glucose control or cause weight regain
The SELECT cardiovascular outcomes trial (N=17,604), published in NEJM 2023 (DOI: 10.1056/NEJMoa2307563), demonstrated a 20% reduction in major adverse cardiovascular events (MACE) -- the composite of cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke -- in overweight or obese adults without diabetes
L-glutachion yeast extract 30.77% (Dutch), fullerene, vitamin C, lemon juice powder [dextrin, lemon juice (100% American), arabic gum, citric acid, admixture (jujeong, purified water, natural flavoring), hydroxypropyl methylcellulose, enzyme-treated stevia, milkseed extract (American), natural extract (Clorine), vitamin E, vitamin E *Contains Milk